Excel’s SAB is critical in helping identify investment opportunities and in conducting due diligence. They also help portfolio companies find solutions to challenges in technology development.

Anthony Atala, M.D. - Professor and Chair (Urology) and Director, Wake Forest Institute for Regenerative Medicine, Wake Forest University School of Medicine; Co-founder Tengion, Inc.

George Canellos, M.D. - Senior Physician, Dana Farber Cancer Institute; William Rosenberg Professor of Medicine, Harvard Medical School; Senior Physician, Brigham and Women's.

James Collins, Ph.D. - Boston University Professor; Professor of Biomedical Engineering; Co-Director, Center for BioDynamics, BU; MacArthur Foundation "Genius"; Co-founder Cellicon.

David Fairchild, M.D. - Chief, General Medicine, Tufts New England Medical Center; Associate Professor of Medicine, Tufts University School of Medicine

Theodor W. Haensch, Ph.D. - Nobel Laureate; Director, Max Planck Institute

Joseph Loscalzo, M.D., Ph.D. - Professor and Chairman, Physician-in-Chief, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School ; co-founder NitroMed

Hamilton O. Smith, Ph.D. - Nobel Laureate; Founder, Celera and Synthetic Genomics

Cornelis Terhorst, Ph.D. Chief, Division of Immunology, Beth Israel Deaconess Medical Center; Professor of Medicine (Immunology), Harvard Medical School

J. Craig Venter, Ph.D. Founder, Human Genome Sciences, Celera, Diversa, Synthetic Genomics; Sequenced the human genome